These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 17543082)

  • 21. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett's esophagus.
    Gaddam S; Mathur SC; Singh M; Arora J; Wani SB; Gupta N; Overhiser A; Rastogi A; Singh V; Desai N; Hall SB; Bansal A; Sharma P
    Am J Gastroenterol; 2011 Nov; 106(11):1961-9. PubMed ID: 21946283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of low-grade dysplasia in Barrett's esophagus.
    Wani S
    Curr Opin Gastroenterol; 2012 Jul; 28(4):370-6. PubMed ID: 22508323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
    Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus.
    Kendall C; Stone N; Shepherd N; Geboes K; Warren B; Bennett R; Barr H
    J Pathol; 2003 Aug; 200(5):602-9. PubMed ID: 12898596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's Esophagus.
    Vennalaganti P; Kanakadandi V; Goldblum JR; Mathur SC; Patil DT; Offerhaus GJ; Meijer SL; Vieth M; Odze RD; Shreyas S; Parasa S; Gupta N; Repici A; Bansal A; Mohammad T; Sharma P
    Gastroenterology; 2017 Feb; 152(3):564-570.e4. PubMed ID: 27818167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the updated confocal laser endomicroscopy criteria for Barrett's esophagus among gastrointestinal pathologists.
    Tofteland N; Singh M; Gaddam S; Wani SB; Gupta N; Rastogi A; Bansal A; Kanakadandi V; McGregor DH; Ulusarac O; Cherian R; Mathur SC; Sharma P
    Dis Esophagus; 2014; 27(7):623-9. PubMed ID: 24006939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus.
    Fortun PJ; Anagnostopoulos GK; Kaye P; James M; Foley S; Samuel S; Shonde A; Badreldin R; Campbell E; Hawkey CJ; Ragunath K
    Aliment Pharmacol Ther; 2006 Mar; 23(6):735-42. PubMed ID: 16556175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists.
    Moole H; Patel J; Ahmed Z; Duvvuri A; Vennelaganti S; Moole V; Dharmapuri S; Boddireddy R; Yedama P; Bondalapati N; Uppu A; Vennelaganti P; Puli S
    World J Gastroenterol; 2016 Oct; 22(39):8831-8843. PubMed ID: 27818599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase).
    Sonwalkar SA; Rotimi O; Scott N; Verghese E; Dixon M; Axon AT; Everett SM
    Histopathology; 2010 Jun; 56(7):900-7. PubMed ID: 20636793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.
    Srivastava A; Hornick JL; Li X; Blount PL; Sanchez CA; Cowan DS; Ayub K; Maley CC; Reid BJ; Odze RD
    Am J Gastroenterol; 2007 Mar; 102(3):483-93; quiz 694. PubMed ID: 17338734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barrett's esophagus: diagnostic challenges and recent developments.
    Maru DM
    Ann Diagn Pathol; 2009 Jun; 13(3):212-21. PubMed ID: 19433303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Veneto Region's Barrett's Oesophagus Registry: aims, methods, preliminary results.
    Zaninotto G; Minnei F; Guirroli E; Ceolin M; Battaglia G; Bellumat A; Betetto G; Bozzola L; Cassaro M; Cataudella G; Dal Bò N; Farinati F; Florea G; Furlanetto A; Galliani E; Germanà B; Guerini A; Macrì E; Marcon V; Mastropaolo G; Meggio A; Miori G; Morelli L; Murer B; Norberto L; Togni R; Valiante F; Rugge M
    Dig Liver Dis; 2007 Jan; 39(1):18-25. PubMed ID: 17141593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining.
    van der Wel MJ; Duits LC; Pouw RE; Seldenrijk CA; Offerhaus GJA; Visser M; Ten Kate FJ; Biermann K; Brosens LAA; Doukas M; Huysentruyt C; Karrenbeld A; Kats-Ugurlu G; van der Laan JS; van Lijnschoten GI; Moll FCP; Ooms AHAG; van der Valk H; Tijssen JG; Bergman JJ; Meijer SL
    Histopathology; 2018 May; 72(6):1015-1023. PubMed ID: 29314176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of "indefinite for dysplasia" grading in Barrett metaplasia.
    Younes M; Lauwers GY; Ertan A; Ergun G; Verm R; Bridges M; Woods K; Meriano F; Schmulen C; Johnson C; Barroso A; Schwartz J; McKechnie J; Lechago J
    Arch Pathol Lab Med; 2011 Apr; 135(4):430-2. PubMed ID: 21466357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of gastrointestinal pathologists within a national digital review panel for Barrett's oesophagus in the Netherlands: results of 80 prospective biopsy reviews.
    Klaver E; van der Wel M; Duits L; Pouw R; Seldenrijk K; Offerhaus J; Visser M; Ten Kate F; Biermann K; Brosens L; Doukas M; Huysentruyt C; Karrenbeld A; Kats-Ugurlu G; van der Laan J; van Lijnschoten I; Moll F; Ooms A; Tijssen J; Meijer S; Bergman J
    J Clin Pathol; 2021 Jan; 74(1):48-52. PubMed ID: 32467320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoplastic precursor lesions in Barrett's esophagus.
    Hornick JL; Odze RD
    Gastroenterol Clin North Am; 2007 Dec; 36(4):775-96, v. PubMed ID: 17996790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing diagnostic accuracy to grade dysplasia in Barrett's esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1.
    Karamchandani DM; Lehman HL; Ohanessian SE; Massé J; Welsh PA; Odze RD; Goldblum JR; Berg AS; Stairs DB
    Diagn Pathol; 2016 Feb; 11():23. PubMed ID: 26926447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's oesophagus.
    Lovat LB; Johnson K; Mackenzie GD; Clark BR; Novelli MR; Davies S; O'Donovan M; Selvasekar C; Thorpe SM; Pickard D; Fitzgerald R; Fearn T; Bigio I; Bown SG
    Gut; 2006 Aug; 55(8):1078-83. PubMed ID: 16469795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.